04.07.2022 • NewsLanxessmicrobialsflavors and fragrances

Lanxess Wraps up IFF Microbial Unit Buy

German specialty chemicals producer Lanxess has wrapped up its acquisition of International Flavors & Fragrances’s microbial control business unit, a year after announcing the $1.3 billion deal with the US company in August 2021.

© Lanxess
© Lanxess

With the closing, Lanxess rises into the ranks of the world’s largest producers, significantly increasing its portfolio of antimicrobial active ingredients and formulations for material protection, preservatives and disinfectant while strengthening the Cologne-based company’s global presence, especially in the US.

Lanxess CEO Matthias Zachert said the acquisition is “another major boost” for the chemical producer’s Consumer Protection business, which will soon become its strongest segment and is “an important engine” in its stability and profitability drive.

Zachert said more than 250 “highly qualified” new employees will join Lanxess, which is now focusing its efforts on “rapidly integrating the newly acquired business” that will contribute annual sales of $450 million, along with some $100 million in EBITDA.

The transfer to Lanxess, though on schedule, required some time as the business that once belonged Dow Chemical and later to DuPont, before being sold to IFF, first had to be carved out of the flavors and fragrances group.

Author: Dede Williams, Freelance Journalist                      

Company

Logo:

LANXESS Deutschland GmbH

Kennedyplatz 1
50569 Köln
Germany

Company contact







Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.